Metsera’s (NASDAQ:MTSR – Get Free Report) quiet period is set to expire on Wednesday, March 12th. Metsera had issued 15,277,778 shares in its initial public offering on January 31st. The total size of ...
4don MSN
We recently published a list of 10 Stocks With At Least $20 Million In Insider Spending Recently. In this article, we are ...
Last September, another obesity-focused biotech, BioAge, completed an upsized IPO that raised $198 million, after the number of shares on offer was hiked by 40%. Metsera's lead asset is MET-097i ...
Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the Nasdaq this year, raising $275 million and $140 million, respectively.
The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.
Explore Metsera stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MTSR. Why Did MTSR Stock Surge 15% On The Worst Trading Day Of 2025? Here's What Has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback